Derek T. Chalmers's most recent trade in Tvardi Therapeutics Inc. was a trade of 20,000 Common Stock done at an average price of $15.5 . Disclosure was reported to the exchange on Sept. 7, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.47 per share. | 07 Sep 2021 | 20,000 | 991,405 (2%) | 0% | 15.5 | 309,400 | Common Stock |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 30 Aug 2021 | 8,440 | 1,011,405 (2%) | 0% | 14.2 | 119,848 | Common Stock |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2021 | 17,334 | 1,019,845 (2%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 103,000 | 103,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 52,000 | 1,002,511 (2%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 10,000 | 953,614 (2%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 17.98 per share. | 04 Mar 2021 | 3,103 | 950,511 (2%) | 0% | 18.0 | 55,792 | Common Stock |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 18,750 | 955,343 (2%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 19.33 per share. | 23 Feb 2021 | 11,729 | 943,614 (2%) | 0% | 19.3 | 226,722 | Common Stock |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.30 per share. | 30 Dec 2020 | 6,078 | 936,593 (2%) | 0% | 15.3 | 92,993 | Common Stock |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2020 | 18,750 | 947,671 (2%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 23 Dec 2020 | 5,000 | 942,671 (2%) | 0% | 16 | 80,000 | Common Stock |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 14.95 per share. | 16 Dec 2020 | 5,000 | 928,921 (1%) | 0% | 15.0 | 74,750 | Common Stock |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.29 per share. | 10 Dec 2020 | 7,500 | 933,921 (1%) | 0% | 15.3 | 114,675 | Common Stock |
| Tvardi Therapeutics Inc | Derek T. Chalmers | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 17 Nov 2020 | 11,799 | 941,421 (2%) | 0% | 16 | 188,784 | Common Stock |